Physician profile
Laura Scott
NPI 1467768358
$850.80
in general payments reported to CMS, 2019-2025
17 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $144 · 2023: $219 · 2024: $357 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $161.33 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Antares Pharma, INC. | $114.84 | 2023 | Nocdurna, Xyosted, Tlando |
| Astrazeneca Pharmaceuticals LP | $107.47 | 2023-2024 | Airsupra, Farxiga, Breztri |
| Esperion Therapeutics, INC. | $87.91 | 2021 | |
| Axsome Therapeutics, INC. | $54.14 | 2024-2025 | Auvelity, Symbravo |
| Exact Sciences Corporation | $49.77 | 2023-2024 | Cologuard Collection Kit |
| Abbvie INC. | $41.89 | 2024-2025 | |
| Lilly USA, LLC | $33.04 | 2024-2025 | Jardiance |
| Dexcom, INC. | $32.39 | 2024 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $30.79 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.44 | 2024 | Jardiance |
| Medtronic, INC. | $24.57 | 2023 | Venaseal |
| Abbott Laboratories | $23.40 | 2021 | |
| Phathom Pharmaceuticals, INC. | $18.85 | 2024 | Voquezna |
| Pfizer INC. | $17.41 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.21 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.35 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.